Barības vada atrēzijas miniinvazīvas ārstēšanas iespējas, rezultāti - literatūras apskats
No Thumbnail Available
Date
2022
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Rīgas Stradiņa universitāte
Rīga Stradiņš University
Rīga Stradiņš University
Abstract
Barības vada atrēzija (BVA) ar vai bez traheoesofageālo fistulu (TEF) tiek iekļauta iedzimtu slimību grupā ar līdz galam neizzinātu etioloģiju. Barības vada atrēzija skar 1:2500–1:4500 dzīvi dzimušo bērnu visā pasaulē (Sfeir et al., 2013). Pirmā torakoskopiskā metodā pie BVA tika veikts 1999.gadā un 2000.gadā šo metodi pielietoja pie BVA ar distālu TEF (Teague and Karpelowsky, 2016). Neskatoties uz to, ka dzīvildze ir uzlabojusies, bērniem ar BVA joprojām ir daudz un dažādu izaicinājumu pirmsoperatīvajā, operatīvajā un pēcoperatīvajā periodā. Šajā literatūras apskatā galvenā uzmanība tiek vērsta uz miniinvazīvu ārstēšanas metožu pielietošanu un to salīdzināšana ar konvencionālām metodēm, komplikāciju biežumu un komplikāciju ārstēšanas iespējām.
Šī tēma ir aktuāla, jo mūsdienās joprojām novēro augsto BVA un TEF izplatību gan pasaulē, gan Eiropā un trūkst vienprātības speciālistu vidū par izmantotās ārstēšanas metodes zelta standartu.
Esophageal atresia (EA) with or without tracheoesophageal fistula (TEF) is included in the group of congenital diseases with completely unknown etiology. Esophageal atresia affects on average 1:2500–1:4500 live births neonates (Sfeir et al., 2013). The first thoracoscopic method at EA was performed in 1999, and this method was applied to EA with distal TEF in 2000 (Teague and Karpelowsky, 2016). Although survival has been improved, there are still many different challenges in the preoperative, operative and postoperative period for children with EA. This literature review focuses on the miniinvasive treatment methods and their comparison with conventional methods, the frequency and treatment options of complications. This topic is relevant because the prevalence of EA and TEF is still high today in the world including Europe. There is a lack of consensus among professionals about the gold standard of the treatment method.
Esophageal atresia (EA) with or without tracheoesophageal fistula (TEF) is included in the group of congenital diseases with completely unknown etiology. Esophageal atresia affects on average 1:2500–1:4500 live births neonates (Sfeir et al., 2013). The first thoracoscopic method at EA was performed in 1999, and this method was applied to EA with distal TEF in 2000 (Teague and Karpelowsky, 2016). Although survival has been improved, there are still many different challenges in the preoperative, operative and postoperative period for children with EA. This literature review focuses on the miniinvasive treatment methods and their comparison with conventional methods, the frequency and treatment options of complications. This topic is relevant because the prevalence of EA and TEF is still high today in the world including Europe. There is a lack of consensus among professionals about the gold standard of the treatment method.
Description
Pediatrija
Pediatrics
Veselības aprūpe
Health Care
Pediatrics
Veselības aprūpe
Health Care
Keywords
barības vada atrēzija (BVA), traheoesofageālā fistula, torakoskopija, torakotomija, barības vada atrēzijas komplikācijas, esophageal atresia(EA), tracheoesophageal fistula, thoracoscopy, thoracotomy, esophageal atresia complications